We learn from the clinical experiences of our patients and improve drugs to better serve their needs
Sarfez’s innovative product development strategy shortens the product development timeline and reduces risk. These efficiencies are transferred to patients and payers in the form of reasonable drug costs and price transparency.
Virtual model to maximize cost efficiencies
Alliances with specialized and best-in-the class companies
Government non-diluted funding
Academic knowledge and expertise
Patient experiences to develop optimal solutions
Our strategies leverage patient experiences, expertise of our partners, knowledge of academics and funding from government resources:
